LENZ Therapeutics Statistics
Total Valuation
LENZ has a market cap or net worth of $182.24 million. The enterprise value is -$37.20 million.
| Market Cap | 182.24M |
| Enterprise Value | -37.20M |
Important Dates
The last earnings date was Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LENZ has 31.42 million shares outstanding. The number of shares has increased by 10.84% in one year.
| Current Share Class | 31.42M |
| Shares Outstanding | 31.42M |
| Shares Change (YoY) | +10.84% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 2.65% |
| Owned by Institutions (%) | 73.66% |
| Float | 18.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.49 |
| Forward PS | 7.57 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.55, with a Debt / Equity ratio of 0.00.
| Current Ratio | 13.55 |
| Quick Ratio | 12.91 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.21% and return on invested capital (ROIC) is -39.69%.
| Return on Equity (ROE) | -59.21% |
| Return on Assets (ROA) | -37.36% |
| Return on Invested Capital (ROIC) | -39.69% |
| Return on Capital Employed (ROCE) | -61.84% |
| Weighted Average Cost of Capital (WACC) | 13.17% |
| Revenue Per Employee | $141,283 |
| Profits Per Employee | -$828,961 |
| Employee Count | 152 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LENZ has paid $5,000 in taxes.
| Income Tax | 5,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.99% in the last 52 weeks. The beta is 1.63, so LENZ's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | -84.99% |
| 50-Day Moving Average | 5.27 |
| 200-Day Moving Average | 11.71 |
| Relative Strength Index (RSI) | 64.82 |
| Average Volume (20 Days) | 710,044 |
Short Selling Information
The latest short interest is 11.20 million, so 35.63% of the outstanding shares have been sold short.
| Short Interest | 11.20M |
| Short Previous Month | 11.32M |
| Short % of Shares Out | 35.63% |
| Short % of Float | 60.87% |
| Short Ratio (days to cover) | 11.44 |
Income Statement
In the last 12 months, LENZ had revenue of $21.48 million and -$126.00 million in losses. Loss per share was -$4.12.
| Revenue | 21.48M |
| Gross Profit | 19.70M |
| Operating Income | -135.66M |
| Pretax Income | -126.00M |
| Net Income | -126.00M |
| EBITDA | -135.20M |
| EBIT | -135.66M |
| Loss Per Share | -$4.12 |
Balance Sheet
The company has $220.00 million in cash and $569,000 in debt, with a net cash position of $219.43 million or $6.98 per share.
| Cash & Cash Equivalents | 220.00M |
| Total Debt | 569,000 |
| Net Cash | 219.43M |
| Net Cash Per Share | $6.98 |
| Equity (Book Value) | 219.26M |
| Book Value Per Share | 6.98 |
| Working Capital | 216.07M |
Cash Flow
In the last 12 months, operating cash flow was -$113.91 million and capital expenditures -$511,000, giving a free cash flow of -$114.42 million.
| Operating Cash Flow | -113.91M |
| Capital Expenditures | -511,000 |
| Depreciation & Amortization | 453,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -114.42M |
| FCF Per Share | -$3.64 |
Margins
| Gross Margin | 91.74% |
| Operating Margin | -631.70% |
| Pretax Margin | -586.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LENZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.84% |
| Shareholder Yield | -10.84% |
| Earnings Yield | -69.14% |
| FCF Yield | -62.79% |
Analyst Forecast
The average price target for LENZ is $24.00, which is 313.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $24.00 |
| Price Target Difference | 313.79% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 70.44% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LENZ has an Altman Z-Score of 20.12 and a Piotroski F-Score of 2.
| Altman Z-Score | 20.12 |
| Piotroski F-Score | 2 |